Yuliya Lytvyn

3.0k citations
90 papers · 1.9k indexed · 1 hit paper · h-index 23

Yuliya Lytvyn

82 papers receiving 1.9k citations

Hit Papers

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure3322017202620202023100200300

Peers

Yuliya Lytvyn
Comparison fields: 5 of 111
  • Nephrology 518
  • Endocrinology, Diabetes and Metabolism 1000
  • Cardiology and Cardiovascular Medicine 321
  • Dermatology 112
  • Surgery 541
Replace Ling Yu with:
Ling Yu China
Noritaka Kawada Japan
José Barbosa United States
Mojca Jensterle Slovenia
Johannes Jacobi Germany
Derun Taner Ertuğrul Türkiye
Wojciech Zgliczyński Poland
Bernhard Böhm Germany
Mitsushige Nishikawa Japan
Suzanne L. Advani Canada
Yuliya Lytvyn relative to Ling Yu China Ling Yu's profile →
Citations per field
00.5×5.6×
Ling Yu · 1×
Citations per year

Countries citing papers authored by Yuliya Lytvyn

Since Specialization
Citations

This map shows the geographic impact of Yuliya Lytvyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuliya Lytvyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuliya Lytvyn more than expected).

Fields of papers citing papers by Yuliya Lytvyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuliya Lytvyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuliya Lytvyn. The network helps show where Yuliya Lytvyn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuliya Lytvyn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuliya Lytvyn Line = papers co-authored together Yuliya Lytvyn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20242
3 20240
4 20231
5 20233
6 20233
7 20236
8 202320
9 202241
10 20223
11 20212
12 20216
13 20209
14 20205
15 20201
16 201911
17 20191
18 201630
19 201315
20 201122

About Yuliya Lytvyn

Yuliya Lytvyn is a scholar working on Nephrology, Dermatology and Endocrinology, Diabetes and Metabolism, having authored 90 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (16 papers), Chronic Kidney Disease and Diabetes (13 papers), Blood Pressure and Hypertension Studies (11 papers), Diabetes Management and Research (9 papers), Psoriasis: Treatment and Pathogenesis (9 papers), Dialysis and Renal Disease Management (8 papers), Dermatology and Skin Diseases (8 papers) and Diabetes and associated disorders (7 papers). The work is most often cited by research in Nephrology (518 citations), Endocrinology, Diabetes and Metabolism (1000 citations) and Cardiology and Cardiovascular Medicine (321 citations). Yuliya Lytvyn has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include David Z.I. Cherney, Petter Bjornstad, Bruce A. Perkins, Julie A. Lovshin, Jacob A. Udell, Harindra Rajasekeran, Marko Škrtić, Paul S. F. Yip, Asfandyar Mufti and Daniël H. van Raalte. Their work appears in journals such as Circulation, PLoS ONE and Endocrine Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026